Related Experiment Video

Updated: Feb 10, 2026

Phase Transitions and Effect of Intermolecular Forces
02:31

Phase Transitions and Effect of Intermolecular Forces

23.3K

HDL cholesterol and protective factors in atherosclerosis

Gerd Assmann1, Antonio M Gotto

  • 1Institute of Clinical Chemistry and Laboratory Medicine, Central Laboratory, Westphalian Wilhelms-University, Munster, Germany. assmann@uni-muenster.de

Circulation
|June 17, 2004
PubMed

Insights

Low high-density lipoprotein cholesterol (HDL-C) is a significant cardiovascular disease risk factor. While HDL-C

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Preventive Medicine

Background:

  • Low high-density lipoprotein cholesterol (HDL-C) is a recognized risk factor for cardiovascular disease (CVD).
  • Epidemiological and clinical studies demonstrate a correlation between HDL-C levels and the incidence of coronary events.
  • The cardioprotective mechanisms of HDL-C involve reverse cholesterol transport, endothelial cell function, and antioxidant properties.

Purpose of the Study:

  • To review the role of HDL-C in cardiovascular disease.
  • To discuss the evidence supporting HDL-C's cardioprotective effects.
  • To evaluate the current therapeutic recommendations for HDL-C.

Main Methods:

  • Literature review of epidemiological and clinical studies.
  • Analysis of data from clinical trials investigating HDL-C-raising therapies.
  • Examination of current clinical guidelines regarding lipid management.

Main Results:

  • Evidence links low HDL-C levels to increased cardiovascular event rates.
  • HDL-C possesses multiple cardioprotective functions, including reverse cholesterol transport and antioxidant activity.
  • Clinical trials provide some evidence for HDL-C-raising benefits, but further research is required.

Conclusions:

  • Low HDL-C is a significant cardiovascular risk factor that warrants consideration in patient management.
  • While not a primary therapeutic target, HDL-C levels should be evaluated within the broader context of a patient's overall cardiovascular risk profile.
  • Further research is necessary to fully elucidate the therapeutic potential of targeting HDL-C for cardiovascular risk reduction.

More Related Videos

Transition Metals: Electron Configurations and Properties02:58

Transition Metals: Electron Configurations and Properties

30.0K
Cooperative Allosteric Transitions: Concerted & Sequential Model01:58

Cooperative Allosteric Transitions: Concerted & Sequential Model

8.8K

Related Concept Videos

Phase Transitions02:31

Phase Transitions

Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to...
23.3K
Properties of Transition Metals02:58

Properties of Transition Metals

Transition metals are defined as those elements that have partially filled d orbitals. As shown in Figure 1, the d-block elements in groups 3–12 are transition elements. The f-block elements, also called inner transition metals (the lanthanides and actinides), also meet this criterion because the d orbital is partially occupied before the f orbitals.
30.0K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.8K
Phase Transitions: Vaporization and Condensation02:39

Phase Transitions: Vaporization and Condensation

The physical form of a substance changes on changing its temperature. For example, raising the temperature of a liquid causes the liquid to vaporize (convert into vapor). The process is called vaporization—a surface phenomenon. Vaporization occurs when the thermal motion of the molecules overcome the intermolecular forces, and the molecules (at the surface) escape into the gaseous state. When a liquid vaporizes in a closed container, gas molecules cannot escape. As these gas phase molecules...
21.5K
Phase Transitions: Sublimation and Deposition02:33

Phase Transitions: Sublimation and Deposition

Some solids can transition directly into the gaseous state, bypassing the liquid state, via a process known as sublimation. At room temperature and standard pressure, a piece of dry ice (solid CO2) sublimes, appearing to gradually disappear without ever forming any liquid. Snow and ice sublimate at temperatures below the melting point of water, a slow process that may be accelerated by winds and the reduced atmospheric pressures at high altitudes. When solid iodine is warmed, the solid sublimes...
20.3K
Phase Transitions: Melting and Freezing02:39

Phase Transitions: Melting and Freezing

Heating a crystalline solid increases the average energy of its atoms, molecules, or ions, and the solid gets hotter. At some point, the added energy becomes large enough to partially overcome the forces holding the molecules or ions of the solid in their fixed positions, and the solid begins the process of transitioning to the liquid state or melting. At this point, the temperature of the solid stops rising, despite the continual input of heat, and it remains constant until all of the solid is...
15.2K